Complex ventral hernia repair using components separation with or without biologic mesh: A cost-utility analysis

摘要

We commend Dr Chatterjee and colleagues for advancing the discussion beyond short-term comparisons of acquisition cost or profit and loss assessments, common in a number of recent papers assessing financial implications of using biologic acellular dermal matrices for surgical repair in complex ventral hernias. The authors have raised the bar to a broader "value for money" framework, and to our knowledge, this is the first analysis that considers the impact of using biologic mesh to patients in terms of an assessment of quality-adjusted life years (QALYs).